Chinese firm eyes to invest in Tanzania’s Mloganzila medical devices hub
DAR ES SALAAM: A Chinese pharmaceutical technology company has expressed interest in investing in Tanzania’s pharmaceutical and medical devices manufacturing hub at Mloganzila, in a move expected to boost local production and reduce the country’s dependence on imported health products.
This was reached in a discussion between Tanzania’s Minister for Health Mohamed Mchengerwa during his visit to the headquarters of Shandong Hongyu Medical Technology Group Co., Ltd in Weihai in China, where he held talks with the company’s Board Chairman, Miao Yingyang.
Speaking at the meeting, the minister stated that the company is among strategic investors considering setting up pharmaceutical and medical device manufacturing facilities at the Mloganzila Special Economic Zone in Dar es Salaam.
He said the government is committed to attracting more investment into the sector by providing a predictable and investor-friendly business environment.
ALSO READ: BoT complaint system cuts financial disputes
“The government will continue working closely with strategic investors to accelerate the growth of Tanzania’s pharmaceutical manufacturing industry,” he said.
The minister described the Mloganzila Special Economic Zone as a flagship project that will position Tanzania as a regional production hub for medicines and medical devices, supplying both the domestic market and neighbouring countries in East and Southern Africa.
He said the Ministry of Health will actively facilitate investments to ensure projects are implemented efficiently, adding that Tanzania’s legal and regulatory framework provides transparent procedures for investors.
Mr Mchengerwa said expanding domestic production of medicines and medical equipment remains a key government priority to strengthen health security, guarantee the availability of essential medical products and cut reliance on imports.
He added that Tanzania’s drive to build a self-reliant health sector will be achieved through long-term partnerships with reputable investors committed to supporting the country’s healthcare and industrial development agenda.
This version hits the main news in the first sentence, cuts the diplomatic language, and reads more like a business/investment story than a government press release.
